Diseases

A new experimental system shows how insulin-producing beta cells react under autoimmune attack during type 1 diabetes; the results could lead to better treatments.

A new MIT course on the COVID-19 pandemic, available to the public online, brings together top COVID-19 experts to educate students on up-to-date pandemic science.

On this episode of AudioHelicase podcast, Whitehead Fellow Olivia Corradin talked about investigating the genetic underpinnings of diseases through a new technique she developed, the outside variant approach. Applying the method to study the autoimmune disease multiple sclerosis (MS), Corradin and colleagues identified a role for a cell type in the brain in MS, offering a new way of understanding the disease. 

Xin Tang is a postdoc in Whitehead Institute Member Rudolf Jaenisch’s lab investigating brain disease and developing approaches to discover new therapies. We sat down with Tang to learn more about him and his experiences in and out of the lab.

Researchers in Richard Young’s lab at Whitehead Institute and collaborators have discovered how certain cancer therapeutics concentrate within cells -- a finding that could change the way scientists think about drug design.

Weiskopf will be studying how existing FDA-approved drugs could be repurposed to reduce the severity and mortality of the disease.

Differently shaped RNA molecules allow HIV to express different genes from the same RNA sequence.

Elizabeth Boydston is a postdoc in Whitehead Institute Member Sebastian Lourido’s lab investigating the pathogen Toxoplasmsa gondii. We sat down with Boydston to learn more about her and her experiences in and out of the lab.

Anushka Dongre is a postdoc in Whitehead Institute Member Robert (Bob) Weinberg’s lab investigating how cancers spread and how the body’s own immune system can be used to fight them.